Abstract
Purpose
This study investigated psychological morbidity, quality of life (QoL), colorectal cancer (CRC)-specific symptoms and supportive care needs in a CRC population at the end of treatment (EOT).
Methods
CRC survivors (n = 152) completed a post-treatment baseline questionnaire as part of a multisite supportive care randomised controlled trial (SurvivorCare). CRC survivors had completed treatment with curative intent within 0 to 6 months. Measures are as follows: Brief Symptom Inventory 18 (BSI-18) (psychological morbidity), EORTC QLQ-C30 and QLQ-CR29 (QoL and CRC-specific symptoms and problems) and Cancer Survivors’ Unmet Needs (CaSUN) measure with a simplified response format (unmet needs). Linear regression models were used to compare participants’ QoL with a general population sample. Correlation analysis examined associations between psychological morbidity, QoL and CRC-specific symptoms and problems.
Results
Average participant age was 64 years, and 51 % were male. The majority (68 %) had stage 3 disease. In comparison to population norms, CRC survivors had lower depression and anxiety scores (47.4 and 45.6, respectively) but higher somatisation, and lower role, cognitive and social functioning (p < 0.001). CRC survivors had higher fatigue, nausea/vomiting, appetite loss, diarrhoea and financial problems (all p < 0.001), as well as pain (p = 0.002) and constipation (p = 0.019). CRC-specific psychological scores were positively correlated with all three BSI domain scores, and pain and fatigue symptom scores on the QLQ-C30 while negatively correlated with all five functional scales of the QLQ-C30.
Conclusions
CRC survivors reported good mental health at EOT. Role and social functioning were impaired compared to population norms, possibly related to physical symptoms.
Implications for Cancer Survivors
Findings may help guide consultations with patients and inform the design of more tailored supportive care interventions.
Trial registration: ACTRN12610000207011
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer; 2013.
Cancer Institute NSW. Cancer survival in New South Wales 2002–06. Sydney: Cancer Institute NSW; 2012.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.
Australian Institute of Health and Welfare 2012. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cancer Series no. 69. Cat. no. CAN 65. Canberra: AIHW.: Australian Institute of Health and Welfare 2012.
Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JDF, et al. How much can current interventions reduce colorectal cancer mortality in the US? Cancer. 2006;107(7):1624–33.
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73.
Binefa G, Rodriguez-Moranta F, Teule A, Medina-Hayas M. Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol. 2014;20(22):6786–808.
Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol. 2004;22(23):4829–36.
Nikoletti S, Young J, Levitt M, King M, Chidlow C, Hollingsworth S. Bowel problems, self-care practices, and information needs of colorectal cancer survivors at 6 to 24 months after sphincter-saving surgery. Cancer Nurs. 2008;31(5):389–98.
Hewitt M GS, Stovall E. From cancer patient to cancer survivor: lost in transition: National Academies Press; 2005.
Jefford M, Karahalios E, Pollard A, Baravelli C, Carey M, Franklin J, et al. Survivorship issues following treatment completion-results from focus groups with Australian cancer survivors and health professionals. J Cancer Surviv. 2008;2(1):20–32.
Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol. 2006;24(32):5101–4.
Graça Pereira M, Figueiredo AP, Fincham FD. Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs. 2012;16(3):227–32.
Chambers SK, Meng X, Youl P, Aitken J, Dunn J, Baade P. A five-year prospective study of quality of life after colorectal cancer. Qual Life Res. 2012;21(9):1551–64.
Lynch BM, Steginga SK, Hawkes AL, Pakenham KI, Dunn J. Describing and predicting psychological distress after colorectal cancer. Cancer. 2008;112(6):1363–70.
Dunn J, Ng SK, Holland J, Aitken J, Youl P, Baade PD, et al. Trajectories of psychological distress after colorectal cancer. Psychooncology. 2013;22(8):1759–65.
Jefford M, Aranda S, Gough K, Lotfi-Jam K, Butow P, Krishnasamy M, et al. Evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors: study protocol for a randomized controlled trial. Trials. 2013;14:260.
Jefford M, Lotfi-Jam K, Baravelli C, Grogan S, Rogers M, Krishnasamy M, et al. Development and pilot testing of a nurse-led posttreatment support package for bowel cancer survivors. Cancer Nurs. 2011;34(3):E1–E10.
Derogatis LR. BSI-18: administration, scoring and procedures manual. Minneapolis: National Computer Systems; 2000.
Zabora J, Brintzenhofeszoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001;42(3):241–6.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.
Whistance R, Conroy T, Chie W, Costantini A, Sezer O, Koller M, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009;45(17):3017–26.
Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Lo SK, et al. The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (Cancer Survivors’ Unmet Needs measure). Psychooncology. 2007;16(9):796–804.
Hodgkinson K. Scoring manual for the CaSUN and CaSPUN. 2007. Available from: http://www.headwayhealth.com.au/wp-content/uploads/2014/01/Manual-for-the-CASUN-and-CaSPUN-questionnaires.pdf. Retrieved 01 April, 2014.
Giese-Davis J, Waller A, Carlson LE, Groff S, Zhong L, Neri E, et al. Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age. BMC Cancer. 2012;12(1):441.
Bland JM, Altman DG. Statistics notes: matching. BMJ. 1994;309(6962):1128.
Cocks K, King MT, Velikova G, St-James MM, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29(1):89–96.
R Development Core team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014. Available from: http://www.R-project.org/.
Hervé M. RVAideMemoire 2014. Available from: http://cran.r-project.org/web/packages/RVAideMemoire/index.html
Cohen J. Statistical power analysis for the behavioral sciences: Hillsdale. NJ: Lawrence Erlbaum Associates; 1988.
Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54(4):343–9.
Nordin K, Glimelius B. Psychological reactions in newly diagnosed gastrointestinal cancer patients. Acta Oncol. 1997;36(8):803–10.
Herman JM, Narang AK, Griffith KA, Zalupski MM, Reese JB, Gearhart SL, et al. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2013;85(1):e15–9.
Theodoropoulos G, Papanikolaou I, Karantanos T, Zografos G. Post-colectomy assessment of gastrointestinal function: a prospective study on colorectal cancer patients. Tech Coloproctol. 2013;17(5):525–36.
Hsu T, Ennis M, Hood N, Graham M, Goodwin PJ. Quality of life in long-term breast cancer survivors. J Clin Oncol. 2013;31(28):3540–8.
Rogers SN, Harvey-Woodworth CN, Hare J, Leong P, Lowe D. Patients’ perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg. 2012;50(5):410–6.
Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system. Support Care Cancer. 2013;21(1):107–17.
Donovan KA, Thompson LM, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control. 2010;17(1):44–51.
Scarpa M, Di Cristofaro L, Cortinovis M, Pinto E, Massa M, Alfieri R, et al. Minimally invasive surgery for colorectal cancer: quality of life and satisfaction with care in elderly patients. Surg Endosc. 2013;27(8):2911–20.
Boltong A, Aranda S, Keast R, Wynne R, Francis PA, Chirgwin J, et al. A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes. PLoS One. 2014;9(7):e103512.
Garofalo JP, Choppala S, Hamann HA, Gjerde J. Uncertainty during the transition from cancer patient to survivor. Cancer Nurs. 2009;32(4):E8–E14.
Salz T, Baxi SS, Blinder VS, Elkin EB, Kemeny MM, McCabe MS, et al. Colorectal cancer survivors’ needs and preferences for survivorship information. J Oncol Pract. 2014:JOP. 2013.001312.
Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013;22(5):978–86.
Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11.
Purim O, Gordon N, Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit. 2013;19:203–9.
Acknowledgments
The authors would like to thank all patients for volunteering their time to make this study possible. QLQ-C30 normative data were provided by Professor Madeleine King, The University of Sydney, on behalf of the MAUCa Consortium. Dr. Daniel Costa provided data management for the QLQ-C30 normative data. We also thank Lisa Demosthenous, Matthew Holmes, Anna Ugalde and Felicity Pendergast for their involvement with SurvivorCare.
Conflict of interest
This project was funded by the Victorian Cancer Agency: Grant number: EOI09_74 and Cancer Australia/Beyond Blue: Grant number: 628581. The funding bodies had no role in the design of the study nor in the collection, analysis and interpretation of data, or writing of the manuscript. Jane Young is supported by a Cancer Institute NSW Academic Leader in Cancer Epidemiology Award.
Lahiru Russell, Karla Gough, Allison Drosdowsky, Penelope Schofield, Sanchia Aranda, Phyllis N Butow, Jennifer A Westwood, Mei Krishnasamy, Jo Phipps-Nelson and Michael Jefford declare that they have no conflict of interest.
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Russell, L., Gough, K., Drosdowsky, A. et al. Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment. J Cancer Surviv 9, 462–470 (2015). https://doi.org/10.1007/s11764-014-0422-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-014-0422-y